People · Operator
Named in public records as an officer, director or promoter · active 2009–2022 · Biotechnology
| Company | Role | Sector | Stage | Raised · real | Value · est | Tied |
|---|---|---|---|---|---|---|
| KBI Biopharma Inc. | — | Biotechnology | Series A | $9.6M | $347.0M | 2009 |
| Altis Biosystems, Inc. | — | Biotechnology | Seed | $6.6M | $6.8M | 2019 |
Joseph McMahon at the center, the companies they're named on, and every other operator named alongside them — an interlock map of shared founding teams, boards and funds. Name-matched, so treat as a research lead.
People named alongside Joseph McMahon on the same companies — an interlock signal (shared founding team, board, or fund). Name-matched, so verify before acting.
| Operator | Shared | Their companies |
|---|---|---|
| Christopher Sims | 1 | 5 |
| Michael Dial | 1 | 4 |
| Nicholas J. Leb | 1 | 3 |
| Benjamin Scruggs | 1 | 3 |
| Susan Mahony | 1 | 2 |
| Michael Biron | 1 | 1 |
| James Hoover | 1 | 1 |
| Howard Auman, Jr. | 1 | 1 |
| Harrington Bischof | 1 | 1 |
| Richard Brandewie | 1 | 1 |
| Christopher Perkins | 1 | 1 |
| Jimmy Smedley | 1 | 1 |
| Kevin Causey | 1 | 1 |
| Samuel Franklin | 1 | 1 |
People are matched by normalized name across records; a common name may merge distinct individuals. Treat as a research lead, the same way modeled valuations are directional, not quoted.